Sickle cell anemia and thalassemia both affect hemoglobin, but in different ways. We review the key differences.

Poikilocytosis is the presence of abnormal shaped red blood cells. Learn more about what causes it, symptoms of poikilocytosis, and more.

Thalassemia is a genetic blood disorder that impacts the ability of the blood to get oxygen to the body’s organs. Learn about the signs, how it’s diagnosed & treated.

A Northeast Ohio woman and a 22-year-old man from UAE are among the first patients to receive the innovative CRISPR treatment.

Red blood cells are an important component of blood. They transport gasses such as oxygen and carbon dioxide throughout the human body.

The decision comes after Vertex Pharmaceuticals and CRISPR Therapeutics’ Casgevy was approved in the UK and US for sickle cell disease and beta thalassemia.

In sickle cell disease and beta thalassemia, patients don’t produce healthy hemoglobin, the substance in red blood cells responsible for carrying oxygen throughout the body.

Vertex sickle cell drug, based on novel gene-editing technology, wins approval in UK New therapy, the first using CRISPR/Cas9 tools, will also treat beta thalassemia ...

The red cell distribution width (RDW) blood test measures how equal your red blood cells are in size. One of several tests included in a complete blood count (CBC), RDW is measured as a percentage.

Thalassemia is an inherited blood disorder affecting hemoglobin synthesis, leading to anemia; diagnosis and treatment options are discussed.

Here are some key questions (and answers) about the approval of Casgevy, a treatment for sickle cell disease and beta thalassemia.